The Chemours
CC
10.88
-0.92
-7.80%
The Chemours
US · CC
#2748 by market cap
Listed 1970
10.88
-0.92
-7.80%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:47
Quant vs Street three independent views, side by side
StockVane factor grade
D
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
3
■ Upgrades■ Downgrades
- 0 upgrades vs 3 downgrades among tracked analyst rating changes.
- Most recent: Mizuho Securities moved from Buy to Hold on 2026-10-13.
Analyst consensus 9 analysts
Buy
Avg price target 16.89 +55.2%
Price target rangecurrent 10.88
Low14.00
Avg16.89
High22.00
Buy 33%
Hold 67%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-09 | J.P. Morgan | -- | Hold | 14.00 |
| 2026-11-04 | UBS | -- | Hold | 15.00 |
| 2026-11-04 | Barclays | -- | Hold | 16.00 |
| 2026-11-04 | RBC Capital | -- | Hold | 14.00 |
| 2026-11-03 | Morgan Stanley | -- | Hold | 18.00 |
| 2026-11-02 | BMO Capital | -- | Buy | 18.00 |
| 2026-10-20 | Truist Financial | -- | Buy | 20.00 |
| 2026-10-13 | Mizuho Securities | -- | Hold | 15.00 |
| 2026-10-12 | Barclays | -- | Hold | 16.00 |
| 2026-10-12 | RBC Capital | -- | Hold | 14.00 |
| 2026-10-05 | UBS | -- | Hold | 16.00 |
| 2026-10-05 | BMO Capital | -- | Buy | 18.00 |
| 2026-09-30 | Mizuho Securities | -- | Buy | 18.00 |
| 2026-09-23 | Mizuho Securities | -- | Buy | 20.00 |
| 2026-09-11 | Truist Financial | -- | Buy | -- |
| 2026-08-24 | UBS | -- | Hold | -- |
| 2026-08-24 | Goldman Sachs | -- | Hold | 17.00 |
| 2026-08-19 | Alembic Global | -- | Buy | 22.00 |
| 2026-08-13 | BMO Capital | -- | Buy | 18.00 |
| 2026-08-10 | UBS | -- | Hold | 18.00 |
| 2026-08-10 | Morgan Stanley | -- | Hold | 18.00 |
| 2026-08-06 | Truist Financial | -- | Buy | 24.00 |
| 2026-08-05 | Mizuho Securities | -- | Buy | 22.00 |
| 2026-08-05 | Morgan Stanley | -- | Hold | 21.00 |
| 2026-08-05 | RBC Capital | -- | Buy | 22.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-13 | Mizuho Securities | Buy → Hold | 15.00 |
| 2026-10-12 | RBC Capital | Buy → Hold | 14.00 |
| 2026-08-10 | UBS | Buy → Hold | 18.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-02 | After close | ±12.38% | -0.53% (in line) |
| 2026/Q2 | 2026-08-04 | After close | ±10.72% | -18.63% (beat) |
| 2026/Q1 | 2026-05-05 | After close | ±12.27% | -15.28% (beat) |
| 2025/Q4 | 2026-02-19 | After close | ±12.14% | -16.51% (beat) |
| 2025/Q3 | 2025-11-06 | After close | ±13.82% | +6.56% (in line) |
| 2025/Q2 | 2025-08-05 | After close | ±12.19% | -4.99% (in line) |
| 2025/Q1 | 2025-05-06 | After close | ±11.97% | -9.92% (in line) |
| 2024/Q4 | 2025-02-18 | -- | ±11.46% | +3.86% (in line) |
| 2024/Q3 | 2024-11-04 | -- | ±10.92% | +15.49% (beat) |
| 2024/Q2 | 2024-08-01 | After close | ±10.02% | -11.88% (beat) |
| 2024/Q1 | 2024-04-30 | After close | ±7.06% | -2.80% (in line) |
| 2023/Q4 | 2024-03-27 | After close | ±9.20% | -9.07% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:47:46 · For reference only, not investment advice and not tailored to your situation.
The Chemours discussion 0 comments